Form 4: Albert Friedberg Reports Acquisition of Vaccinex Shares and Warrants
SEC Form 4
Albert Friedberg, a director and 10% owner of Vaccinex, Inc., reports the acquisition of shares and warrants, along with adjustments due to a reverse stock split.
Summary
- Albert Friedberg, a director and 10% owner of Vaccinex, Inc. (VCNX), filed a Form 4 detailing changes in beneficial ownership.
- The report includes transactions from March 28, 2024, and reflects a 1-for-14 reverse stock split that occurred on February 19, 2024.
- Friedberg acquired 102,960 shares of common stock at a price of $7.77 per share.
- He also acquired warrants to purchase 102,960 shares of common stock with an exercise price of $7.64, expiring on March 28, 2029.
- The reported securities are also indirectly held by Pan Atlantic Holdings Ltd., Friedberg Global-Macro Hedge Fund Ltd., and FCMI Parent Co., entities in which Friedberg has a significant interest.
- Friedberg disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a regulatory filing detailing transactions. The acquisition of shares by a director could be seen as positive, but the reverse stock split introduces some caution.
Positives
- The acquisition of shares and warrants by a director and significant shareholder could be interpreted as a sign of confidence in the company's future prospects.
Risks
- Friedberg disclaims beneficial ownership of the indirectly held shares except to the extent of his pecuniary interest, which could indicate a complex ownership structure.
- The reverse stock split may have been implemented to increase the stock price and maintain listing requirements, which can sometimes be a sign of underlying financial challenges.
Industry Context
Form 4 filings are a standard part of regulatory compliance for individuals with significant ownership in publicly traded companies, providing transparency into their transactions.
Stakeholder Impact
- The acquisition of shares and warrants by a director and significant shareholder could positively influence shareholder sentiment.
- The reverse stock split may impact shareholder value, depending on the company's future performance.
Key Dates
| Date | Description |
|---|---|
| 02/08/2024 | Warrant Expiration Date |
| 02/19/2024 | Vaccinex effected a 1-for-14 reverse stock split |
| 03/28/2024 | Date of transaction: Acquisition of shares and warrants |
| 03/28/2029 | Warrant Expiration Date |
| 10/03/2028 | Warrant Expiration Date |
Keywords
Vaccinex, VCNX, Form 4, Beneficial Ownership, Albert Friedberg, Reverse Stock Split, Warrants, Shares
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.